Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis

Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis

Abstract Introduction Long‐acting injectable cabotegravir (CAB‐LA) demonstrated superiority to daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for human immunodeficiency virus (HIV) pre‐exposure prophylaxis (PrEP) in two clinical trials. This analysis projects the impact of expanding PrE...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah E. Stansfield, Mia Moore, Lise Jamieson, Gesine Meyer‐Rath, Leigh F. Johnson, David Kaftan, Anna Bershteyn, Jennifer Smith, Valentina Cambiano, Loveleen Bansi‐Matharu, Andrew Phillips, Jesse Heitner, Ruanne V. Barnabas, Brett Hanscom, Deborah J. Donnell, Marie‐Claude Boily, Dobromir Dimitrov
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Journal of the International AIDS Society
Subjects:
adherence
CAB‐LA
HIV prevention
modelling
pre‐exposure prophylaxis
South Africa
Online Access:https://doi.org/10.1002/jia2.26453
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jia2.26453

Similar Items